| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | ANGO Angiodynamics Inc | Nighan Warren Jr74 | SVP Quality And Regulatory | Sell | 4,060 | $12.31 | $49,978.60 | -8.8% | -25.9% | -18.2% | |
| Jan 16, 2025 | NEOG Neogen Corp | Naemura David H. | CFO | Buy | 14,800 | $11.11 | $164,428.00 | +31.7% | -60.3% | -20.3% | |
| Jan 16, 2025 | OWLT Owlet, Inc. | Crawford Amanda | Chief Financial Officer | Sell | 182 | $4.30 | $782.60 | -0.1% | -25.0% | +218.1% | |
| Jan 16, 2025 | EW Edwards Lifesciences Corp | Lippis Daniel J.62 | Cvp, Japac | Sell | 500 | $68.76 | $34,382.15 | -2.1% | +1.9% | +20.7% | |
| Jan 16, 2025 | SGHT Sight Sciences, Inc. | Badawi Paul62 | President And CEO | Sell | 24,819 | $2.92 | $72,570.76 | -0.4% | -8.1% | +127.8% | |
| Jan 16, 2025 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 5,000 | $68.75 | $343,735.50 | -9.6% | +1.9% | +20.7% | |
| Jan 16, 2025 | OFIX Orthofix Medical Inc. | Andrews Julie55 | CFO | Sell | 4,655 | $17.89 | $83,277.95 | -14.1% | -27.7% | -21.6% | |
| Jan 16, 2025 | NEOG Neogen Corp | Adent John Edward49 | CEO | Buy | 23,035 | $11.03 | $254,076.05 | +9.4% | -60.3% | -20.3% | |
| Jan 16, 2025 | RXST Rxsight, Inc. | Corley Jesse Anderson | Director | Buy | 3,210 | $31.15 | $100,004.19 | +222.5% | -53.4% | -68.5% | |
| Jan 16, 2025 | STAA Staar Surgical Co | Broadwood Partners, L.P.60 | 10% Owner | Buy | 29,376 | $21.47 | $630,838.87 | - | -26.1% | -4.0% | |
| Jan 16, 2025 | OWLT Owlet, Inc. | Harris Jonathan | President &CRO | Sell | 24,179 | $4.40 | $106,435.55 | -4.1% | -25.0% | +218.1% | |
| Jan 15, 2025 | PDEX Pro Dex Inc | Cabillot Raymond E66 | Director, 10% Owner | Sell | 3,026 | $45.18 | $136,714.68 | -0.4% | +41.1% | -7.9% | |
| Jan 14, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 11,547 | $0.74 | $8,521.69 | - | -7.4% | -4.9% | |
| Jan 14, 2025 | SERA Sera Prognostics, Inc. | Phillips Joshua74 | Director | Sell | 34,211 | $6.74 | $230,468.54 | -38.1% | -47.6% | -44.4% | |
| Jan 14, 2025 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 29,591 | $6.80 | $201,133.27 | -5.7% | -47.6% | -44.4% | |
| Jan 13, 2025 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 33,227 | $0.81 | $26,913.87 | -3.7% | -8.7% | -57.7% | |
| Jan 13, 2025 | BVS Bioventus Inc. | Claypoole Robert E | President And CEO | Sell | 28,786 | $9.10 | $261,952.60 | -30.7% | -13.5% | -15.9% | |
| Jan 13, 2025 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 20,492 | $0.81 | $16,598.52 | -9.1% | -8.7% | -57.7% | |
| Jan 13, 2025 | MXCT Maxcyte, Inc. | Sandoval David I. | General Counsel | Sell | 4,466 | $4.54 | $20,271.62 | -9.7% | -47.0% | -73.3% | |
| Jan 13, 2025 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 29,031 | $0.81 | $23,515.11 | -9.4% | -8.7% | -57.7% | |
| Jan 13, 2025 | OM Outset Medical, Inc. | Nash Marc83 | SVP Operations And R&D | Sell | 15,011 | $0.81 | $12,158.91 | -6.3% | -8.7% | -57.7% | |
| Jan 13, 2025 | PDEX Pro Dex Inc | Cabillot Raymond E66 | Director, 10% Owner | Sell | 4,824 | $46.93 | $226,407.84 | -0.7% | +26.9% | -13.7% | |
| Jan 13, 2025 | OFIX Orthofix Medical Inc. | Gillespie Geoffrey C80 | CAO | Sell | 475 | $16.98 | $8,065.20 | -0.6% | -22.4% | -14.7% | |
| Jan 13, 2025 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 58,521 | $10.71 | $626,590.93 | -5.2% | -6.4% | +51.2% | |
| Jan 13, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner74 | Chief Information Officer | Sell | 16,473 | $7.27 | $119,678.05 | -4.5% | -47.2% | -43.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.